The effect of inflammation on voriconazole trough concentrations in children

por ter Avest, Mendy, Veringa, Anette, van den Heuvel, Edwin R., Kosterink, Jos G. W., Schölvinck, Elisabeth H., Tissing, Wim J. E., Alffenaar, Jan‐Willem C.
Publicado 2016

The potential of individualized dosing of ravulizumab to improve patient‐friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs

por ter Avest, Mendy, Langemeijer, Saskia M.C., Schols, Saskia E.M., Burger, David M., van de Kar, Nicole C.A.J., Blijlevens, Nicole M.A., Kievit, Wietske, ter Heine, Rob
Publicado 2021

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient

por Bouwmeester, Romy N., Ter Avest, Mendy, Wijnsma, Kioa L., Duineveld, Caroline, ter Heine, Rob, Volokhina, Elena B., Van Den Heuvel, Lambertus P. W. J., Wetzels, Jack F. M., van de Kar, Nicole C. A. J.
Publicado 2021

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

por ter Avest, Mendy, Bouwmeester, Romy N, Duineveld, Caroline, Wijnsma, Kioa L, Volokhina, Elena B, van den Heuvel, Lambertus P W J, Burger, David M, Wetzels, Jack F M, van de Kar, Nicole C A J, ter Heine, Rob
Publicado 2022

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

por Bouwmeester, Romy N., Duineveld, Caroline, Wijnsma, Kioa L., Bemelman, Frederike J., van der Heijden, Joost W., van Wijk, Joanna A.E., Bouts, Antonia H.M., van de Wetering, Jacqueline, Dorresteijn, Eiske, Berger, Stefan P., Gracchi, Valentina, van Zuilen, Arjan D., Keijzer-Veen, Mandy G., de Vries, Aiko P.J., van Rooij, Roos W.G., Engels, Flore A.P.T., Altena, Wim, de Wildt, Renée, van Kempen, Evy, Adang, Eddy M., ter Avest, Mendy, ter Heine, Rob, Volokhina, Elena B., van den Heuvel, Lambertus P.W.J., Wetzels, Jack F.M., van de Kar, Nicole C.A.J.
Publicado 2022